Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

V. Misra; R. El Khoury; R. Arora; P.R. Chen; S. Suzuki; N. Harun; N.R. Gonzales; A.D. Barreto; J.C. Grotta; S.I. Savitz

doi:10.3174/ajnr.A2427

Research ArticlePatient SafetyF

Open Access

Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

V. Misra, R. El Khoury, R. Arora, P.R. Chen, S. Suzuki, N. Harun, N.R. Gonzales, A.D. Barreto, J.C. Grotta and S.I. Savitz

American Journal of Neuroradiology June 2011, 32 (6) 998-1001; DOI: https://doi.org/10.3174/ajnr.A2427

V. Misra

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

R. El Khoury

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

R. Arora

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

P.R. Chen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S. Suzuki

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

N. Harun

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

N.R. Gonzales

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

A.D. Barreto

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J.C. Grotta

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

S.I. Savitz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
Responses
References
PDF

Submit a Response to This Article

Compose eLetter

Title *

Contents

More information about text formats

Plain text

No HTML tags allowed.
Web page addresses and e-mail addresses turn into links automatically.
Lines and paragraphs break automatically.

Author Information

Contributors
First Name and Middle Initial * First or given name, e.g. 'Peter'. Last Name * Your last, or family, name, e.g. 'MacMoody'. Email Address * Your email address, e.g. [email protected] Occupation * Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Affiliation * Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.

Statement of Competing Interests

Competing interests? *

Yes

Please describe the competing interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.

PreviousNext

In this issue

American Journal of Neuroradiology

Vol. 32, Issue 6

1 Jun 2011

Table of Contents
Index by author

Download PDF

Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

Message Subject (Your Name) has sent you a message from American Journal of Neuroradiology

Message Body (Your Name) thought you would like to see the American Journal of Neuroradiology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cite this article

V. Misra, R. El Khoury, R. Arora, P.R. Chen, S. Suzuki, N. Harun, N.R. Gonzales, A.D. Barreto, J.C. Grotta, S.I. Savitz

Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

American Journal of Neuroradiology Jun 2011, 32 (6) 998-1001; DOI: 10.3174/ajnr.A2427

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

0 Responses

Respond to this article

Bookmark this article

User Name *

Password *

Remember my user name & password.

Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

V. Misra, R. El Khoury, R. Arora, P.R. Chen, S. Suzuki, N. Harun, N.R. Gonzales, A.D. Barreto, J.C. Grotta, S.I. Savitz

American Journal of Neuroradiology Jun 2011, 32 (6) 998-1001; DOI: 10.3174/ajnr.A2427

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Purchase

Jump to section

Article
Figures & Data
Info & Metrics
Responses
References
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial

Crossref (9)
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke

Rais Reskiawan A. Kadir, Ulvi Bayraktutan

Cellular and Molecular Neurobiology 2020 40 3
Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke

KIYOSHI KIKUCHI, NAOKI MIURA, KO-ICHI KAWAHARA, YOSHINAKA MURAI, MOTOHIRO MORIOKA, PAUL A. LAPCHAK, EIICHIRO TANAKA

Biomedical Reports 2013 1 1
Medical Therapy for Ischemic Stroke: Review of Intravenous and Intra-Arterial Treatment Options

Philipp Taussky, Rabih G. Tawk, Wilson P. Daugherty, Ricardo A. Hanel

World Neurosurgery 2011 76 6
Efficacy and Safety Evaluation on Arterial Thrombolysis in Treating Acute Cerebral Infarction

Baozhong Shen, Qingan Liu, Yingli Gu, Yan Wang, Zhuobo Zhang

Cell Biochemistry and Biophysics 2015 73 2
Neuroprotective Therapy for Stroke and Ischemic Disease

Paul A. Lapchak, Paul D. Boitano

2017
Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial

Shuya Li, Hong-Qiu Gu, Hongguo Dai, Guozhi Lu, Yongjun Wang

Stroke and Vascular Neurology 2024 9 5
Efficacy of urokinase and alteplase intravenous thrombolysis in the treatment of acute phase cerebral infarction and impact on serum S-100β and nerve growth factor levels

Lei Zhang, Si Wang, Nannan Ren

International Journal of Neuroscience 2025 135 6
Neurointervention in the Medical Specialties

Vivek Misra, Lee A. Birnbaum

2015
Neurointervention in the Medical Specialties

Anqi Luo, Vivek Misra, Lee A. Birnbaum

2022

Main menu

User menu

Search

American Journal of Neuroradiology

Safety of High Doses of Urokinase and Reteplase for Acute Ischemic Stroke

Plain text

Vertical Tabs

Jump to comment:

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Indexed Content

Cases

More from AJNR

Multimedia

Resources

About Us

American Society of Neuroradiology